Literature DB >> 10362107

Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.

S L Gibson1, J J Havens, M L Nguyen, R Hilf.   

Abstract

Recently, considerable interest has been given to photodynamic therapy of cancer using delta-aminolaevulinic acid to induce protoporphyrin IX as the cell photosensitizer. One advantage of this modality is that protoporphyrin IX is cleared from tissue within 24 h after delta-aminolaevulinic acid administration. This could allow for multiple treatment regimens because of little concern regarding the accumulation of the photosensitizer in normal tissues. However, the haem biosynthetic pathway would have to be fully functional after the first course of therapy to allow for subsequent treatments. Photosensitization of cultured R3230AC rat mammary adenocarcinoma cells with delta-aminolaevulinic acid-induced protoporphyrin IX resulted in the inhibition of porphobilinogen deaminase, an enzyme in the haem biosynthetic pathway, and a concomitant decrease in protoporphyrin IX levels. Cultured R3230AC cells exposed to 0.5 mM delta-aminolaevulinic acid for 27 h accumulated 6.07 x 10(-16) mol of protoporphyrin IX per cell and had a porphobilinogen deaminase activity of 0.046 fmol uroporphyrin per 30 min per cell. Cells cultured under the same incubation conditions but exposed to 30 mJ cm(-2) irradiation after a 3-h incubation with delta-aminolaevulinic acid showed a significant reduction in protoporphyrin IX, 2.28 x 10(-16) mol per cell, and an 80% reduction in porphobilinogen deaminase activity to 0.0088 fmol uroporphyrin per 30 min per cell. Similar effects were evident in irradiated cells incubated with delta-aminolaevulinic acid immediately after, or following a 24 h interval, post-irradiation. There was little gain in efficacy from a second treatment regimen applied within 24 h of the initial treatment, probably a result of initial metabolic damage leading to reduced levels of protoporphyrin IX. These findings suggest that a correlation may exist between the delta-aminolaevulinic acid induction of porphobilinogen deaminase activity and the increase in intracellular protoporphyrin IX accumulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362107      PMCID: PMC2363048          DOI: 10.1038/sj.bjc.6690454

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

Review 1.  Preclinical examination of first and second generation photosensitizers used in photodynamic therapy.

Authors:  C J Gomer
Journal:  Photochem Photobiol       Date:  1991-12       Impact factor: 3.421

Review 2.  5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.

Authors:  Q Peng; K Berg; J Moan; M Kongshaug; J M Nesland
Journal:  Photochem Photobiol       Date:  1997-02       Impact factor: 3.421

3.  Photodynamic therapy using mTHPC for malignant disease in the oral cavity.

Authors:  K F Fan; C Hopper; P M Speight; G A Buonaccorsi; S G Bown
Journal:  Int J Cancer       Date:  1997-09-26       Impact factor: 7.396

4.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats.

Authors:  R Van Hillegersberg; J W Van den Berg; W J Kort; O T Terpstra; J H Wilson
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

5.  Effect of UVA and blue light on porphyrin biosynthesis in epidermal cells.

Authors:  D He; S Sassa; H W Lim
Journal:  Photochem Photobiol       Date:  1993-05       Impact factor: 3.421

Review 6.  Porphyrins, porphyrias, cancer and photodynamic therapy--a model for carcinogenesis.

Authors:  A M Batlle
Journal:  J Photochem Photobiol B       Date:  1993-09       Impact factor: 6.252

Review 7.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.

Authors:  J C Kennedy; R H Pottier
Journal:  J Photochem Photobiol B       Date:  1992-07-30       Impact factor: 6.252

8.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

Authors:  L Wyld; J L Burn; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins.

Authors:  Z Malik; H Lugaci
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations.

Authors:  N van der Veen; H L van Leengoed; W M Star
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  1 in total

Review 1.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.